[Federal Register Volume 61, Number 66 (Thursday, April 4, 1996)]
[Notices]
[Page 15119]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-8305]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 12 of the Code of Federal 
Regulations (CFR), this is notice that on January 26, 1996, Ganes 
Chemicals, Inc., Industrial Park Road, Pennsville, New Jersey 08070, 
made application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule 
------------------------------------------------------------------------
Methylphenidate (1724).....................................          II 
Amobarbital (2125).........................................          II 
Pentobarbital (2270).......................................          II 
Secobarbital (2315)........................................          II 
Glutethimide (2550)........................................          II 
Methadone (9250)...........................................          II 
Methadone-intermediate (9254)..............................          II 
Dextropropoxyphene, bulk (non-dosage forms (9273)..........          II 
------------------------------------------------------------------------

    The firm plans to manufacture the controlled substances for 
distribution as bulk product to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than June 3, 1996.

    Dated: March 27, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-8305 Filed 4-3-96; 8:45 am]
BILLING CODE 4410-09-M